MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

BJDX — Bluejay Diagnostics, Inc. Common Stock

Nasdaq

Bluejay Diagnostics, Inc. Common Stock

CompareBack to Screener
$0.84
-0.01(-1.12%)
O
0.85
H
0.85
L
0.83
V
112.46K
⏱️ End-of-day dataAs of Oct 2, 2026

Chart

About BJDX

Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.

IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
SectorNot available
IPO DateNov 10, 2021
Employees6
Stock ExchangeNasdaq
Ticker SymbolBJDX

Key Financial Statistics

Market Cap$953.3K
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$0.80 - $16.68
52-Week Avg Volume1.88M
VWAP$0.84
Transactions845
Total Recorded Bars1,228 days